1. AB0692 Effects of intravenous golimumab on patient-reported outcomes in active ankylosing spondylitis: 28-week results of the phase III go-alive trial. (15th June 2017) Authors: Reveille, JD; Deodhar, A; Chan, EK; Peterson, S; Li, N; Hsia, E; Kim, L; Lo, KH; Harrison, DD; Han, C Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0348 Safety and efficacy of intravenous golimumab in adult patients with active ankylosing spondylitis: results through week 28. (15th June 2017) Authors: Deodhar, A; Reveille, JD; Harrison, DD; Kim, L; Lo, KH; Hsia, E Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0360 Improvements in sleep problems and pain in patients with active ankylosing spondylitis treated with intravenous golimumab: 28-week results of the phase iii go-alive trial. (15th June 2017) Authors: Deodhar, A; Reveille, JD; Chan, EK; Peterson, S; Li, N; Hsia, E; Kim, L; Lo, KH; Harrison, DD; Han, C Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 341 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0486 Intravenous golimumab in adult patients with active psoriatic arthritis: efficacy and safety through week 24. (15th June 2017) Authors: Kavanaugh, A; Husni, ME; Harrison, DD; Kim, L; Lo, KH; Hsia, EC Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 671 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗